Literature DB >> 21227892

Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo.

Kio Park, Tomoko Mori, Motonobu Nakamura, Yoshiki Tokura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21227892     DOI： 10.1684/ejd.2010.1196

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  8 in total

Review 1.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

Review 2.  Prurigo Simplex or "Itchy Red Bump" Disease: Review and Case Series.

Authors:  Joanna Wallengren
Journal:  Acta Derm Venereol       Date:  2021-09-03       Impact factor: 3.875

Review 3.  Interleukin-31: a novel diagnostic marker of allergic diseases.

Authors:  Anja Rabenhorst; Karin Hartmann
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

4.  Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.

Authors:  Micah Belzberg; Martin Prince Alphonse; Isabelle Brown; Kyle A Williams; Raveena Khanna; Byron Ho; Shannon Wongvibulsin; Thomas Pritchard; Youkyung Sophie Roh; Nishadh Sutaria; Justin Choi; Jaroslaw Jedrych; Andrew D Johnston; Kakali Sarkar; Chirag Vasavda; Jimmy Meixiong; Carly Dillen; Kent Bondesgaard; John F Paolini; Wei Chen; David Corcoran; Nicolas Devos; Madan M Kwatra; Anna L Chien; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-03-23       Impact factor: 7.590

5.  Dermal Periostin: A New Player in Itch of Prurigo Nodularis.

Authors:  Takashi Hashimoto; Leigh A Nattkemper; Hei Sung Kim; Christina D Kursewicz; Emilie Fowler; Serena M Shah; Sonali Nanda; Rachel A Fayne; Paolo Romanelli; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2021-01-20       Impact factor: 3.875

Review 6.  Interleukin-31 as a Clinical Target for Pruritus Treatment.

Authors:  Kenji Kabashima; Hiroyuki Irie
Journal:  Front Med (Lausanne)       Date:  2021-02-12

7.  Increased IL-31 expression in serum and tissue protein in prurigo nodularis.

Authors:  Suteeraporn Chaowattanapanit; Rachot Wongjirattikarn; Nipon Chaisuriya; Piti Ungarreevittaya; Pirawan Poosekeaw; Kengkart Winaikosol; Charoen Choonhakarn; Narachai Julanon; Kanin Salao
Journal:  Ther Adv Chronic Dis       Date:  2022-07-19       Impact factor: 4.970

Review 8.  Pruritus as a Distinctive Feature of Type 2 Inflammation.

Authors:  Simone Garcovich; Martina Maurelli; Paolo Gisondi; Ketty Peris; Gil Yosipovitch; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2021-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.